23rd ISSX North American and 35th JSSX Meeting

23rd ISSX North American and 35th JSSX Meeting, 10/4/2020 » 10/8/2020; Waikaloa, Hawaii   ... Read More »

ISSX/EACPT 2020 Meeting

ISSX/EACPT 2020 Meeting  06/07-10/2020; GENEVA SWITZERLAND; BOOTH 303 ... Read More »

23rd International Conference on Drug-Drug Interactions

23rd International Conference on Drug-Drug Interactions: June 16-18, 2020; University of Washington; Seattle, WA ... Read More »

ASGCT’s 23rd Annual Meeting

ASGCT's 23rd Annual Meeting; May 12-25, 2020; Boston, MA Booth 1123 ... Read More »

FDA 3D

FDA 3D; Monday, April 20, 2020; WASHINGTON, DC ... Read More »

SOT 59th Annual Meeting and ToxExpo

SOT 59th Annual Meeting and ToxExpo in Anaheim, California, March 15–19, 2020; BOOTH # 800 ... Read More »

Delaware Valley Drug Metabolism Discussion Group (DVDMDG)

Delaware Valley Drug Metabolism Discussion Group (DVDMDG); January 21, 2020 ... Read More »

12th International ISSX Meeting taking place July 28th- 31st , 2019, Portland, OR – booth # 410

ISSX Ancillary Meeting: https://www.issx2019.org/ INTEGRATING HUMAN INTESTINAL MUCOSA, INTESTINAL MICROBIOME, AND HUMAN HEPATOCYTES IN THE ASSESSMENT OF HUMAN DRUG PROPERTIES. Inaugural Hepatic and Enteric Research Organizations (HERO) Workshop Monday, July 29, 2019 (17:45 – 19:45), Portland Ballroom 254-257 Please click the link to register or see agenda (no cost workshop) ... Read More »

MassBio Lunch and Learn

MassBio Lunch and Learn IVAL Contract Research Service: In vitro screening for human-specific adverse drug properties Speaker: Albert P. Li, PhD, President and CEO of IVAL Clinical trial failure is a major challenge for drug development. Reasons for the failures are unexpected adverse drug properties that, due to species difference, ... Read More »